May 5, 2015 4:51 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets.The trailing-twelve-month return on assets at
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is 19.90 percent. AMAG Pharmaceuticals' revenue for the same period is $124.40 million.The trailing-twelve-month return on assets at
Meridian Bioscience, Inc. (NASDAQ: VIVO) is 19.70 percent. Meridian Bioscience's PEG ratio is 1.33.The trailing-twelve-month return on assets at
SurModics, Inc. (NASDAQ: SRDX) is 12.40 percent. SurModics' EPS for the same period is $0.89.The trailing-twelve-month return on assets at
Neogen Corporation (NASDAQ: NEOG) is 8.80 percent. Neogen's profit margin for the same period is 11.70 percent.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.